This table provides information on state and territorial plans for phased allocation of COVID-19 vaccines. As initial supply of COVID-19 vaccines is limited, Governors are focused on prioritizing certain high-risk populations for vaccine allocation through a transparent and equitable process. It outlines state and territorial approaches according to Phases 1a-c, 2, and 3, however state Phases or Tiers may vary from this structure (e.g. additional phases or more condensed phasing) and such variations are noted where applicable for individual states.
State planning for allocation to critical populations across Phases, including guidance for providers and the public, will continue to evolve and this document will be updated to reflect additional details as they are released. For additional information on allocation of COVID-19 vaccines, including federal recommendations and considerations for states, please see NGA’s Allocating COVID-19 Vaccines In Initial Phases Of Distribution: Federal Recommendations And Considerations For States.
Given the robust and rapid nature of state response efforts, the National Governors Association welcomes feedback on state actions that may be missing or have evolved since the release of this table. If there is information that should be added or amended, please contact Brittney Roy (email@example.com) and Michelle LeBlanc (firstname.lastname@example.org.)
Additional vaccine resources can be found here.
Vaccine available to 16+ population
- Vaccine available to 16+ population
- Vaccine eligibility for 16+ opening soon
All NGA coronavirus memos can be found here, or visit Coronavirus: What You Need To Know for current information on actions States/Territories are taking to address the COVID-19 pandemic; as well as advocacy, policy, and guidance documents for protecting public health and the economy.